Switzerland· 67893002
Doptelet
A avatrombopag product containing avatrombopagum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Avatrombopag is registered in 15 of 19 countries.
Countries holding a registration under ATC B02BX08 (avatrombopag), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 9 of them publish a price we can compare per daily dose
Avatrombopag · ATC B02BX08
15 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of avatrombopag costs, country by country.
Normalised to the WHO defined daily dose (20 mg), so markets compare like for like.
- Switzerland: $82.67 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Avatrombopag · price per daily dose (20 mg)
USD · FX 28 Sept 2026
- CH Switzerland$82.67
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- avatrombopagum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- B02BX08
- ATC class
- Avatrombopag
- Defined daily dose
- 20 mg, O
- Swissmedic category
- A
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin7680678930026Blist 15 StkCHF 1028.45
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
59 interactions on record for avatrombopag.
Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Avatrombopag · interactions on record
59 records
- 14 severe
- 45 moderate
Most severe, free to view
- FluconazoleJ02AC01severe
- RifampicinJ04AB02severe
- RifapentineJ04AB05severe
- ImatinibL01EA01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Avatrombopag in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDOPTELETSwedish Orphan Biovitrum AB (publ), Stockholm
- BelgiumDoptelet 20 mgSwedish Orphan Biovitrum (Publ)
- IrelandDoptelet 20 mg film-coated tabletsSwedish Orphan Biovitrum AB(publ)
- IcelandDoptelet*Swedish Orphan Biovitrum AB (publ)
- NetherlandsDoptelet 20 mg, filmomhulde tabletSwedish Orphan Biovitrum AB (publ)
- NorwayDopteletSwedish Orphan Biovitrum AB (1)
- PolandDopteletSwedish Orphan Biovitrum AB (publ)
- SwedenDoptelet 20 mg Filmdragerad tablettSwedish Orphan Biovitrum AB (publ)
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Doptelet
- Liechtenstein · Doptelet
- Norway · Doptelet
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/079fec05-15eb-4c1a-ac80-c86467b3fb3b GET /v1/drugs/079fec05-15eb-4c1a-ac80-c86467b3fb3b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "avatrombopagum 20 mg",
"valid_from": "2022-01-01",
"limitations": "[{\"description\":\"Zur Behandlung einer schweren Thrombozytopenie bei erwachsenen Patienten mit chronischer Lebererkrankung (CLD), bei denen ein invasiver Eingriff geplant ist und die zu Beginn der Behandlung eine Thrombozytenzahl von mindestens 20 * 10<sup>9</sup>/L aufweisen.<br>\\nZur Behandlung von erwachsenen Patienten mit chronischer Immunthrombozytopenie (immunthrombozytopenischer Purpura, ITP) definiert als eine mindestens 12 Monate ab Diagnose dauernde ITP. Die Patienten müssen auf mindestens eine vorherige Behandlung (zum Beispiel Kortikosteroide, Azathioprin oder Immunglobuline) unzureichend angesprochen haben. DOPTELET darf nicht in Kombination mit REVOLADE oder NPLATE verabreicht werden.<br>\\n<br>\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2022-01-01\",\"validTo\":null}]",
"galenic_form": "Filmtabl 20 mg",
"therapeutic_area": null,
"sl_inclusion_date": "2022-01-01",
"self_retention_pct": 10
}See everything about avatrombopag.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.